Additive manufacturing (3D printing) permits the fabrication of tablets in shapes unattainable by powder compaction, and so the effects of geometry on drug release behavior is easily assessed. Here, tablets (printlets) comprising of paracetamol dispersed in polyethylene glycol were printed using stereolithographic 3D printing. A number of geometric shapes were produced (cube, disc, pyramid, sphere and torus) with either constant surface area (SA) or constant surface area/volume ratio (SA/V). Dissolution testing showed that printlets with constant SA/V ratio released drug at the same rate, while those with constant SA released drug at different rates. A series of tori with increasing SA/V ratio (from 0.5 to 2.4) were printed, and it was found that dissolution rate increased as the SA/V ratio increased. The data show that printlets can be fabricated in multiple shapes and that dissolution performance can be maintained if the SA/V ratio is constant or that dissolution performance of printlets can be fine-tuned by varying SA/V ratio. The results suggest that 3D printing is therefore a suitable manufacturing method for personalized dosage forms.
INTRODUCTION
The development of new actives with high potencies and narrow therapeutic indices combined with the increasing desire for personalisation of medicines (in terms of dose strength and/or drug combinations) are driving factors changing the landscape of pharmaceutical manufacturing, compelling the pharmaceutical industry to consider new methods of pharmaceutical production. The advent of 3D printing (3DP), and the range of technologies developed, has resulted in a new era of additive manufacturing approaches in which material is deposited layer-by-layer to fabricate solid objects. 3DP offers many qualities ideally suited to meet the challenges facing the pharmaceutical sector; small production runs, infinite variability of dose and/or drug combinations and the possibility to use a wide range of excipients to solubilise, target or control drug release (1).
The kinetics of drug release from oral dosage forms can be influenced by different parameters including dimension and shape (2-4). Karasulu et al. (5) found that the dissolution rate from erodible polymeric tablets containing theophylline was affected by the geometrical shape, polymer ratio and inclusion of diluents in the formulation, concluding that geometry played an important role in determining drug release rates. Raju et al. (6) also reported that the drug release from hydrophilic polymeric tablets was directly related to the surface area to volume ratio (SA/V) of the tablets.
One limitation of these studies is that to create multiple tablet, geometries require production of specific molds. In this aspect, 3D printing offers great potential, because it allows the fabrication of varied and complex shapes, designed with computer-aided design (CAD) software (1,7-9). Previously (10), we investigated the effect that geometry had on the drug release of paracetamolloaded (4% wt./wt.) polyvinyl alcohol (PVA) 3D-printed tablets (Printlets®). Using a fused deposition modeling (FDM) 3D printer, we fabricated printlets in five geometric shapes that would have been difficult to achieve with traditional powder compaction. The results showed surface area to volume ratio (SA/V) was the dominant factor influencing drug release. However, variations in drug release rates between geometries were seen because erosion of the tablet occurred during dissolution.
In this work, we explore the effect of geometry on drug release from cross-linked polymeric printlets, created with stereolithography (SLA) 3D printing. With this technology, a laser is focused into a resin tank, causing photopolymerization of the resin. By moving the laser in a raster pattern, objects can be created in a layer-by-layer fashion. To enhance the speed of photopolymerization, a photoinitiator (PI) is used. A PI absorbs energy to produce an initiating species (often a free radical) which is then able to first attack a monomer and then add consecutively other monomers to this growing polymer chain (11) . Since this process occurs in three dimensions, it yields a cross-linked network. Additional excipients (not involved in the photopolymerization process) can become entrapped in the cross-linked network, enabling the possibility of fabricating drug-loaded tablets.
MATERIALS AND METHODS
Polyethylene glycol diacrylate (PEGda, average MW 700), diphenyl(2,4,6-trimethylbenzoyl) phosphine oxide (TPO) and paracetamol were purchased from SigmaAldrich Ltd. (UK). The salts for preparing the buffer dissolution media were purchased from VWR International Ltd., Poole, UK. All materials were used as received.
Resin Preparation
PEGda was used as the photopolymerizable resin, TPO was used as the photoinitiator (2% wt./wt.) and paracetamol was used as a model drug (4% wt./wt.). Briefly, TPO was added to PEGda and kept protected from light with constant stirring until complete dissolution (approximately 45 min). Paracetamol was added next, and stirring continued until complete dissolution (approximately 25 min); the mixture was then transferred into the resin tray of the printer to begin the fabrication of the tablets.
3D Printing
All printlets were fabricated with a Formlabs 1+ SLA 3D printer (Formlabs Inc., USA). The printer is equipped with a 405-nm laser and can fabricate objects with a resolution of 300 μm and a layer thickness of 25, 50, 100 or 200 μm. The electronic shapes (Fig. 1) were designed with AutoCAD® 2017 and exported as a stereolithography file (.stl) into the 3D printer software (PreForm Software v. 2.11.1 Formlabs Inc.). The parameters of the printer were set to flexible resin (version 01) with a layer thickness of 0.05 mm. The dimensions of the printlets were measured using an ellectronic calliper (0.150 mm PRO-MAX, Fowler, mod S 235 PAT).
Scanning Electron Microscopy
Surface and cross-section images of the printlets were taken with a scanning electron microscopy (SEM, JSM-840A Scanning Microscope, JEOL GmbH, Eching, Germany). All samples for SEM testing were coated with carbon (∼ 30-40 nm).
Drug Loading
To determine drug concentrations of the printlets, they were crushed using a mortar and pestle and then dissolved in 1 L of deionized water with constant magnetic stirring for 24 h. Samples of the solutions were then filtered through 0.45-μm filters (Millipore Ltd., Ireland). The amount of drug in solution was determined using HPLC (Hewlett Packard 1050 Series HPLC system, Agilent Technologies, UK). The assay entailed a mobile phase consisting of water (85%) and methanol (15%), through an Eclipse Plus C18 5 μm column, 15 × 4.6 cm (Agilent, USA). The mobile phase was pumped at a flow rate of 1 ml/min, and the eluent was screened at a wavelength of 247 nm. The injection volume was 20 μL, and the temperature was kept at ambient. The measurements were made in triplicate.
Dynamic Dissolution Testing Conditions
Drug dissolution profiles for the 3D-printed tablets were obtained with a USP-II apparatus (Model PTWS, Pharmatest, Germany). The hydrogels were placed in 750 mL of 0.1 M HCl for 2 h to simulate the gastric compartment, and then transferred into 950 mL of modified Hanks (mHanks) bicarbonate physiological medium for 35 min (pH 5.6 to 7); 3) and then in modified Krebs buffer (1000 ml) (pH 7 to 7.4 and then to 6.5). The modified Hanks buffer-based dissolution medium (12) forms an in situ modified Kreb's buffer (13) by addition of 50 mL of pre-Krebs solution to each dissolution vessel. These conditions mimic transit through the small intestinal and colonic environments. The buffer capacity and ionic composition of the physiological bicarbonate buffers also closely match the buffer capacities of the intestinal fluids collected from different parts of the gut in humans (12) (13) (14) (15) . The paddle speed of the USP-II was fixed at 50 rpm, and the tests were conducted at 37 ± 0.5°C (n = 3). The percentage of drug released from the formulations was determined using HPLC, using the same method as described above.
Statistical analysis was performed using IBM SPSS Statistics 22 software. Comparison of means of drug release during 10 h was analysed using one-way ANOVA-repeated measures, followed by Tukey's HSD post hoc test. P < 0.05 was considered a significant level. To evaluate the relationship between drug release with weight and SA/V, simple and multiple regression analyses were performed.
SA/V Change
The change in SA/V ratio was calculated by measuring the initial dimensions of the printlets and after placing them in 0.1 M HCl for 2 h, then in modified Hanks (mHanks) bicarbonate physiological medium during 22 h at 37°C to simulate the dissolution test conditions. The final SA/V ratio was calculated using Eq. 1.
where SA/V s SA/V for the swollen tablets (after 24 h). SA/V i Initial SA/V.
Swelling Ratio
Printlets were blotted with filter paper to remove any uncured liquid formulation on the surface immediately following printing, then they were weighed (Wi). After this, printlets were placed into HCl (0.1 M) for 2 h then into modified Hanks (mHanks) bicarbonate physiological medium for 8 h; after this, the excess water was carefully wiped off, and the tablets were weighed (Ws). The swelling ratio (SR) was calculated using Eq. 2.
where W s weight of the swollen tablet (after 24 h). W i initial weight of the tablet.
RESULTS
Paracetamol was readily dissolved in PEGda, yielding a clear solution similar to the results obtained by Wang et al. and Martinez et al. (16, 17) , and the laser was able to photocure the resin. Figures 2, 3, and 4 show the various printlets produced, and it is apparent that the SLA printer was able to fabricate them with good resolution. Tables I and II quantify the physical dimensions of the printlets, all of which were close to the target values set in the CAD designs. SEM images of the printlets (Fig. 5) do not show any visible pores, indicating that the resin was photocured with a high cross-linking density.
The average drug content in the printlets was 3.82 ± 0.12% w/w (the expected content based on the resin formulation was 4% w/w), and no degradation peaks were seen in the HPLC chromatograms. This result suggests that there is little drug degradation during printing, which was to be expected since SLA printing involves no significant rise in temperature, and paracetamol does not degrade under light. This is a potential benefit of SLA printing compared with fused deposition modeling (FDM) printing; the latter involves appreciable rises in temperature and has been shown to cause significant drug degradation when used to fabricate polymeric tablets (18) . The slightly lower than the expected concentration might be due to incomplete drug extraction from the cross-linked printlet prior to HPLC analysis; this is an issue seen previously by Wang et al. (16) . Figures 6 and 7 show the drug release profiles from the printlets with similar SA and SA/V ratios. Printlets with similar initial surface areas did not show similar drug release profiles; statistical analysis of the data showed that drug release was significantly different for the sphere (which had the lowest value for SA/V) compared with almost all of the other shapes, except the cylinder. Drug release from the cylinder was significantly different only from the pyramid (which has the highest SA/V ratio). In the case of printlets with similar initial SA/V ratios, the results showed that the percentage of drug released from any shape was not significantly different (p = 0.05). In our previous work (10), it was also noted that the mass of the tablets could influence the drug release kinetics. In this work, we performed simple and multiple regressions to release. Weight is significant in the simple regression (p value = .002) but not in the multiple regression (p value = .350). The coefficient for SA/V is 67.9 in the simple regression and 60.9 in the multiple regression; hence, adjusting for weight decreases the effect of SA/V on drug release. SA/V is significant in both, the simple and the multiple regressions (p value = 0.000 on both). Therefore, SA/V is an important characteristic to predict the speed of drug release after adjusting for weight. The adjusted R square is 0.604, suggesting that approximately 60% of the variation in drug release is explained by its linear relationship with weight and SA/V. The physical parameters of the printlets are shown in Tables I and II . The results show that as the SA/V increases, the speed of drug release does as well. This is in agreement with other studies; Parojcić et al. (19) reported that the drug release kinetics from carbomer matrix tablets can be controlled by modifying the type and content of polymer and the geometry of tablets. In particular, they concluded that the relative surface area (absolute surface area/absolute volume) is a reliable parameter to compare the drug release kinetics from tablets of different shapes. Tablet surface area/volume has also been found to be the most relevant parameter determining the rate of drug release from hydroxypropylmethylcellulose (HPMC) matrix tablets and lipid tablets (2, 20) .
Since SA/V ratio has an important influence on the speed of drug release from 3DP tablets, a group of printlets with a range of different initial SA/V ratios were printed, in order to compare their speed of drug release. All the printlets for this section of the study were tori, as this is the geometry that can be altered to give the widest range of SA/V ratios. Additionally, as noted by Wang et al. (16) , a torus is a complex shape that would be difficult to fabricate using conventional techniques, and it is a shape that has been studied for the possibility to produce tablets with a zero-order release (21, 22) . To achieve a SA/V ratio greater than 1.4, it was necessary to print a tablet comprised of multiple tori; Table III shows the physical parameters of the printlets. Again, the flexibility of 3D printing facilitates the simple manufacture of these very complex shapes. Figure 8 shows the results of drug dissolution for the printlets with different SA/V ratios. The data show that drug release becomes faster as the SA/V increases, confirming the observation reported above that among the parameters affecting drug release kinetics, SA/V plays an important role. It is also clear from these data that 3D printing is a new approach to pharmaceutical manufacturing that allows precise tailoring of dissolution profiles through changing geometry rather than by altering the composition of the formulation (23, 24) .
CONCLUSION
SLA 3DP is suitable for fabricating complex drug-loaded tablets with a good resolution. The results from this work show that of all the geometric parameters, SA/V ratio has the greatest influence on the drug release kinetics from PEGda printlets. One immediate benefit of this outcome is that it will be possible to adjust the dose of printlets so that they are tailored to the needs of an individual patient, but that by changing SA/V ratio the specific drug release profile can be maintained. 
